Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunotherapy in melanoma: Recent advances and future directions.
Franklin C, Livingstone E, Roesch A, Schilling B, Schadendorf D. Franklin C, et al. Among authors: schadendorf d. Eur J Surg Oncol. 2017 Mar;43(3):604-611. doi: 10.1016/j.ejso.2016.07.145. Epub 2016 Sep 2. Eur J Surg Oncol. 2017. PMID: 27769635 Review.
Gene-based therapy of malignant melanoma.
Schadendorf D. Schadendorf D. Semin Oncol. 2002 Oct;29(5):503-12. doi: 10.1053/sonc.2002.35245. Semin Oncol. 2002. PMID: 12407515 Review.
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.
Hauschild A, Weichenthal M, Rass K, Linse R, Ulrich J, Stadler R, Volkenandt M, Grabbe S, Proske U, Schadendorf D, Brockmeyer N, Vogt T, Rompel R, Kaufmann R, Kaatz M, Näher H, Mohr P, Eigentler T, Livingstone E, Garbe C. Hauschild A, et al. Among authors: schadendorf d. J Clin Oncol. 2009 Jul 20;27(21):3496-502. doi: 10.1200/JCO.2008.21.3892. Epub 2009 May 11. J Clin Oncol. 2009. PMID: 19433681 Clinical Trial.
Immunotherapy of distant metastatic disease.
Schadendorf D, Algarra SM, Bastholt L, Cinat G, Dreno B, Eggermont AM, Espinosa E, Guo J, Hauschild A, Petrella T, Schachter J, Hersey P. Schadendorf D, et al. Ann Oncol. 2009 Aug;20 Suppl 6(Suppl 6):vi41-50. doi: 10.1093/annonc/mdp253. Ann Oncol. 2009. PMID: 19617297 Free PMC article. Review.
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
Egberts F, Gutzmer R, Ugurel S, Becker JC, Trefzer U, Degen A, Schenck F, Frey L, Wilhelm T, Hassel JC, Schadendorf D, Livingstone E, Mauch C, Garbe C, Berking C, Rass K, Mohr P, Kaehler KC, Weichenthal M, Hauschild A. Egberts F, et al. Among authors: schadendorf d. Ann Oncol. 2011 Jul;22(7):1667-1674. doi: 10.1093/annonc/mdq648. Epub 2011 Jan 10. Ann Oncol. 2011. PMID: 21220519 Free article. Clinical Trial.
Advances and perspectives in immunotherapy of melanoma.
Schadendorf D, Vaubel J, Livingstone E, Zimmer L. Schadendorf D, et al. Ann Oncol. 2012 Sep;23 Suppl 10:x104-8. doi: 10.1093/annonc/mds321. Ann Oncol. 2012. PMID: 22987943 Free article.
[Immunotherapy of melanomas].
Zimmer L, Vaubel J, Schadendorf D. Zimmer L, et al. Among authors: schadendorf d. Hautarzt. 2012 Dec;63(12):952-8. doi: 10.1007/s00105-012-2470-4. Hautarzt. 2012. PMID: 23097082 Review. German.
1,112 results